Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S et al (2018) Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncol 29(Suppl 4):iv51-67

Article  CAS  Google Scholar 

Garcia-Ortega DY, Villa-Zepeda O, Martinez-Said H, Cuellar-Hübbe M, Luna-Ortiz K (2016) Oncology outcomes in retroperitoneal sarcomas: prognostic factors in a retrospective cohort study. Int J Surg 32:45–49

Fiore M, Brunelli C, Miceli R, Manara M, Lenna S, Rampello NN, ... Gronchi A (2021) A prospective observational study of multivisceral resection for retroperitoneal sarcoma: clinical and patient-reported outcomes 1 year after surgery. Ann Surg Oncol 28:3904–3916

Messiou C, Moskovic E, Vanel D, Morosi C, Benchimol R, Strauss D, ... Bonvalot S (2017) Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm. Ann Surg Oncol (EJSO) 43(7):1191–1198

Blay JY, Hindi N, Bollard J, Aguiar S, Angel M, Araya B, et al. (2022) SELNET clinical practice guidelines for soft tissue sarcoma and GIST [Internet]. Vol. 102, Cancer Treatment Reviews. W.B. Saunders; 2022 [cited 2021 Nov 27]. p. 102312. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0305737221001602

Ruff SM, Grignol VP, Contreras CM, Pollock RE, Beane JD (2022) Morbidity and Mortality after Surgery for Retroperitoneal Sarcoma. Current Oncology 2023, Vol 30, Pages 492–505 [Internet]. 2022 Dec 29 [cited 2023 Apr 1];30(1):492–505. Available from: https://www.mdpi.com/1718-7729/30/1/39/htm

Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P et al (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 27(1):24–30

Article  PubMed  Google Scholar 

Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY et al (2009) Primary retroperitoneal sarcomas: A multivariate analysis of surgical factors associated with local control. J Clin Oncol 27(1):31–37

Article  PubMed  Google Scholar 

Callegaro D, Fiore M, Gronchi A (2015) Personalizing surgical margins in retroperitoneal sarcomas. Expert Rev Anticancer Ther 15(5):553–567

Article  CAS  PubMed  Google Scholar 

Macneill AJ, Gronchi A, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, et al (2018) Postoperative Morbidity after Radical Resection of Primary Retroperitoneal Sarcoma. Ann Surg [Internet]. 2018 May 1 [cited 2021 Jan 12];267(5):959–64. Available from: https://pubmed.ncbi.nlm.nih.gov/28394870/

Viñal D, Martinez D, Garcia-Cuesta JA, Gutierrez-Sainz L, Martinez-Recio S, Villamayor J et al (2020) Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas. Clin Transl Oncol 22(10):1849–1856

Article  PubMed  Google Scholar 

Yali F, Shiwen M, Xing W, Chenghua L, Li L, Jun L et al (2019) Neutrophil to Lymphocyte Ratio in Retroperitoneal Liposarcoma and Other Prognostic Factors. Cancer Res Prevention Treatment 46(02):127–130

Google Scholar 

Liang Y, Wang W, Li J, Guan Y, Que Y, Xiao W et al (2018) Combined use of the neutrophil-lymphocyte and platelet-lymphocyte ratios as a prognostic predictor in patients with operable soft tissue sarcoma. J Cancer 9(12):2132–2139

Article  PubMed  PubMed Central  Google Scholar 

Teck Seo S, Singh VA, Yasin NF (2019) Preoperative lymphocyte count in relation to sarcoma prognosis. J Orthop Surg 27(2):1–7

Article  Google Scholar 

Garcia-Ortega DY, Ponce-Herrera D, Alvarez-Cano A, Caro-Sanchez C, Luna-Ortiz K (2022) Preoperative neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), and platelet to lymphocyte ratio (PLR) as prognostic markers in patients with retroperitoneal liposarcoma. Surgery Practice and Sci 1(9):100076

Article  Google Scholar 

Li A, Wang Z, Lv Q, Ling Y (2022) Prognostic utility of platelet-to-albumin ratio among critically ill patients with colorectal cancer: a propensity score matching study. J Oncol 1:6107997

Aoyama T, Ju M, Komori K, Tamagawa H, Tamagawa A, Morita J et al (2022) Clinical impact of platelet-to-albumin ratio on esophageal cancer patients who receive curative treatment. In Vivo (Brooklyn) [Internet] 36(4):1896–1902

Kucuk A, Topkan E, Selek U, Haksoyler V, Mertsoylu H, Besen AA et al (2022) High measures of pre-chemoradiotherapy platelet-to-albumin ratio indicates poor prognosis in locally advanced pancreatic cancer patients. Ther Clin Risk Manag 18:421–428

Haksoyler V, Topkan E (2021) High pretreatment platelet-to-albumin ratio predicts poor survival results in locally advanced nasopharyngeal cancers treated with chemoradiotherapy. Ther Clin Risk Manag [Internet] 17:691–700

Wang J, Li L, Yu F, Zhang J, Mao L, Chen B et al (2023) Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma. Front Oncol [Internet] 13:1138284. https://www.r-project.org

Shirai Y, Shiba H, Haruki K, Horiuchi T, Saito N, Fujiwara Y, et al (2017) Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection. Anticancer Res [Internet]. 2017 [cited 2023 Mar 24];37(2):787–94. Available from: https://pubmed.ncbi.nlm.nih.gov/28179331/

Huang Z, Zheng Q, Yu Y, Zheng H, Wu Y, Wang Z, et al (2022) Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy. Sci Rep [Internet]. 2022 Dec 1 [cited 2023 Mar 24];12(1). Available from: https://pubmed.ncbi.nlm.nih.gov/35241740/

Guo M, Sun T, Zhao Z, Ming L (2021) Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell Lung Cancer. Ann Thorac Cardiovasc Surg [Internet]. 2021 [cited 2023 Mar 24];27(2):84–90. Available from: https://pubmed.ncbi.nlm.nih.gov/33162436/

Saito N, Shirai Y, Horiuchi T, Sugano H, Shiba H, Sakamoto T, et al (2018) Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma. Anticancer Res [Internet]. 2018 Feb 1 [cited 2023 Mar 24];38(2):987–92. Available from: https://pubmed.ncbi.nlm.nih.gov/29374731/

MacNeill AJ, Miceli R, Strauss DC, Bonvalot S, Hohenberger P, Van Coevorden F, et al (2017) Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group. Cancer [Internet]. 2017 Jun 1 [cited 2021 Jan 12];123(11):1971–8. Available from: https://pubmed.ncbi.nlm.nih.gov/28152173/

Cho CW, Lee KW, Park H, Kim HJ, Park JB, Choi Y La, et al (2018) Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma. Asia Pac J Clin Oncol [Internet]. 2018 Oct 1 [cited 2023 Apr 1];14(5):e465–71. Available from: https://pubmed.ncbi.nlm.nih.gov/29044883/

Callegaro D, Miceli R, Brunelli C, Colombo C, Sanfilippo R, Radaelli S, et al (2015) Long-term morbidity after multivisceral resection for retroperitoneal sarcoma. Br J Surg [Internet]. 2015 Aug 1 [cited 2023 Apr 1];102(9):1079–87. Available from: https://pubmed.ncbi.nlm.nih.gov/26041724/

Stahl CC, Schwartz PB, Ethun CG, Marka N, Krasnick BA, Tran TB, et al (2021) Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database. Ann Surg Oncol [Internet]. 2021 Mar 1 [cited 2023 Apr 1];28(3):1690–6. Available from: https://pubmed.ncbi.nlm.nih.gov/33146839/

Smith HG, Panchalingam D, Hannay JAF, Smith MJF, Thomas JM, Hayes AJ, et al (2023) Outcome following resection of retroperitoneal sarcoma. Br J Surg [Internet]. 2015 Dec 1 [cited 2023 Apr 1];102(13):1698–709. Available from: https://pubmed.ncbi.nlm.nih.gov/26395577/

Hull MA, Niemierko A, Haynes AB, Jacobson A, Chen YL, Delaney TF, et al (2015) Post-operative renal function following nephrectomy as part of en bloc resection of retroperitoneal sarcoma (RPS). J Surg Oncol [Internet]. 2015 Jul 1 [cited 2023 Apr 1];112(1):98–102. Available from: https://pubmed.ncbi.nlm.nih.gov/26179132/

Bonvalot S, Miceli R, Berselli M, Causeret S, Colombo C, Mariani L, et al (2010) Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol [Internet]. 2010 Jun [cited 2023 Apr 1];17(6):1507–14. Available from: https://pubmed.ncbi.nlm.nih.gov/20393803/

Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP (2018) Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection. Ann Surg Oncol [Internet]. 2018 Jan 1 [cited 2023 Apr 1];25(1):98–106. Available from: https://link.springer.com/article/10.1245/s10434-017-6136-4